Bone News and Research

RSS

Case Western Reserve University researchers step up to National Institutes of Health challenge

Futuristic plans to grow replacement organs, bones or muscles for soldiers maimed on the battlefield or patients suffering from debilitating disease or injury won't be anything but science fiction unless new blood vessels can grow into that tissue

14 Oct 2009

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

BioMimetic Therapeutics, Inc. today announced positive top-line results from its North American pivotal (Phase III) randomized controlled trial comparing its fully synthetic, off-the-shelf bone growth factor product, Augment Bone Graft (“Augment”), to autograft for use in hindfoot and ankle fusion surgery.

14 Oct 2009

Endoscopic surgery reduces postoperative discomfort and recovery time

Endoscopic surgery has steadily gained in popularity since it was developed in the 1980s. Dr. Richard Siegfried has teamed with Dr. Louis Quartararo one of only a handful of surgeons who have been trained to perform endoscopic surgery on the spine.

14 Oct 2009

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today it will present new genetic findings in the fields of obesity and osteoporosis at medical meetings later this month.

13 Oct 2009

SANUWAVE presents findings on extracorporeal shock wave stimulation of osteoprogenitor cells

SANUWAVE, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reported that scientific findings titled “Extracorporeal Shock Wave Stimulation of Osteoprogenitor Cells” were presented at the 2009 International Bone-Tissue-Engineering Congress (“Bone-Tec”) in Hannover, Germany, which was held October 9-11, 2009.

13 Oct 2009

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Proteolix, Inc. today announced that it has signed a definitive agreement to be acquired by Onyx Pharmaceuticals, Inc.

13 Oct 2009

Sonitus Medical’s SoundBite hearing system ranks first on Top 10 Medical Innovations for 2010

Sonitus Medical, Inc., a medical device company developing the world's first non-surgical and removable hearing device to transmit sound via the teeth, today announced that technology it developed was ranked #1 on Cleveland Clinic's Top 10 Medical Innovations for 2010.

13 Oct 2009

NIH funds the University of California's consortium for immune disorder research

The University of California, San Francisco has been designated to lead a new consortium that will study a group of severe immune disorders known as primary immunodeficiencies and aims to improve treatment for these often life-threatening diseases. The Primary Immune Deficiency Treatment Consortium comprises 13 centers throughout the United States and has a $6.25 million funding commitment over five years from the National Institutes of Health.

13 Oct 2009

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

In a first-of-its kind procedure, physicians have used stem cells taken from the fat tissue of a 14-year-old boy and combined them with growth protein and donor tissue to grow viable cheek bones in the teen.

13 Oct 2009

Legendary coach helps raise awareness on osteoarthritis

After leading the U.S. men’s basketball team to Olympic gold last year and two weeks before the start of his 30th season as head coach of Duke University’s men’s basketball team, Mike Krzyzewski (Coach K), 61, is teaming up with the Arthritis Foundation to help raise awareness of the disease that nearly ended his coaching career 10 years ago.

13 Oct 2009

Res-Q point-of-care cell processing system from Celling Technologies

Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.

12 Oct 2009

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).

12 Oct 2009

Wake Forest University School of Medicine honours researchers

Wake Forest University School of Medicine honored eight of its researchers with awards for excellence at the 13th Annual Research Awards Day Oct. 1.

12 Oct 2009

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

Fertility and reproductive specialists are invited to join a live, online chat event entitled, “Transvaginal Ultrasound Transfers” at www.CookARTLab.com. The

12 Oct 2009

AACR to host its first Frontiers in Basic Cancer Research Meeting

The American Association for Cancer Research will host its first Frontiers in Basic Cancer Research Meeting in Boston from Oct. 8-11, 2009. The meeting is expected to draw nearly 500 leading scientists to present on high-profile topics like epigenetics, metastasis and systems biology, and create synergies among the many subfields of basic science.

12 Oct 2009

2009 ASH Visitor Training Program to build hematologic capacity in developing countries

The American Society of Hematology (ASH) is proud to announce the participants in the 2009 ASH Visitor Training Program, which builds hematologic capacity in developing countries. Through this program, hematologists and medical professionals from developing countries receive valuable clinical, laboratory, or technological training on a specific topic at a host institution under the mentorship of an ASH member anywhere in the world.

12 Oct 2009

Bone News and Research

Case Western Reserve University researchers step up to National Institutes of Health challenge

Positive results from BioMimetic Therapeutics' Phase III trial comparing Augment Bone Graft to autograft

Endoscopic surgery reduces postoperative discomfort and recovery time

Interleukin Genetics to present new genetic findings on obesity and osteoporosis

SANUWAVE presents findings on extracorporeal shock wave stimulation of osteoprogenitor cells

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Sonitus Medical’s SoundBite hearing system ranks first on Top 10 Medical Innovations for 2010

NIH funds the University of California's consortium for immune disorder research

Surgeons perform groundbreaking procedure using patient's own stem cells for repairing bone deficiencies

Legendary coach helps raise awareness on osteoarthritis

Res-Q point-of-care cell processing system from Celling Technologies

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Wake Forest University School of Medicine honours researchers

Overview of procedures and techniques used for embryo transfer under transvaginal ultrasound guidance

AACR to host its first Frontiers in Basic Cancer Research Meeting

2009 ASH Visitor Training Program to build hematologic capacity in developing countries

NIH awards Beth Israel Deaconess Medical Center $38.2M in grants

First-quarter fiscal 2010 results announced by Biomet

Number of doses, delivery system and setting impact radiation price tag

Three minutes a day to improve posture and spinal health

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News